✦ LIBER ✦

Long-term stable disease in metastatic renal cell carcinoma: sorafenib sequenced to sunitinib and everolimus: a case study

✍ Scribed by Joachim Beck; Joaquim Bellmunt; Bernard Escudier

Book ID: 107577207
Publisher: Springer US
Year: 2010
Tongue: English
Weight: 534 KB
Volume: 28
Category: Article
ISSN: 1357-0560
DOI: 10.1007/s12032-010-9589-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sorafenib in patients with metastatic re

Sorafenib in patients with metastatic renal cell carcinoma refractory to either sunitinib or bevacizumab

✍ Jorge A. Garcia; Thomas E. Hutson; Paul Elson; C. Lance Cowey; Timothy Gilligan; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB 👁 2 views

Skin toxicity and efficacy of sunitinib

Skin toxicity and efficacy of sunitinib and sorafenib in metastatic renal cell carcinoma: a national registry-based study

✍ Poprach, A.; Pavlik, T.; Melichar, B.; Puzanov, I.; Dusek, L.; Bortlicek, Z.; Vy 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 158 KB

Sequential treatment with sorafenib and

Sequential treatment with sorafenib and sunitinib in metastatic renal cell carcinoma: clinical outcomes from a retrospective clinical study

✍ Loukas Kontovinis, Konstantinos Laschos, Alexandra Karadimou, Charalambos Andrea 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 239 KB

Response to Sorafenib After Sunitinib-In

Response to Sorafenib After Sunitinib-Induced Acute Heart Failure in a Patient with Metastatic Renal Cell Carcinoma: Case Report and Review of the Literature

✍ Michael K. K. Wong; Anthony Jarkowski III 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 421 KB

7147 Efficacy and safety of long-term us

7147 Efficacy and safety of long-term use of sorafenib: final report of a phase II trial of sorafenib in Japanese patients with unresectable/metastatic renal cell carcinoma

✍ Akaza, H.; Naito, S.; Tsukamoto, T.; Murai, M.; Fukino, K. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Overall survival and good tolerability o

Overall survival and good tolerability of long-term use of sorafenib after cytokine treatment: final results of a phase II trial of sorafenib in Japanese patients with metastatic renal cell carcinoma

✍ Seiji Naito; Taiji Tsukamoto; Masaru Murai; Koichi Fukino; Hideyuki Akaza 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 411 KB